RBC Capital Reiterates Outperform Rating on Neumora Therapeutics (NMRA)

Go back to RBC Capital Reiterates Outperform Rating on Neumora Therapeutics (NMRA)
(NASDAQ: NMRA) Delayed: 1.73 +0.02 (1.17%)
Previous Close $1.71    52 Week High
Open $1.71    52 Week Low
Day High $1.79    P/E N/A 
Day Low $1.68    EPS
Volume 488,293